Comparison of usability and patient preference for insulin pen needles produced with different production techniques: "thin-wall" needles compared to "regular-wall" needles: An open-label study

Diabetes Technology and Therapeutics

Volumn 11, Issue 8, 2009, Pages 523-528

  Siegmund, Thorsten ^a   Blankenfeld, Hannes ^a   Schumm Draeger, Petra Maria ^a  

^a KLINIKUM BOGENHAUSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DEVICE; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; FEMALE; HEMATOMA; HUMAN; INJECTION; INJECTION PAIN; INSULIN PEN NEEDLE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT DECISION MAKING; PATIENT SATISFACTION; PRIORITY JOURNAL; SKIN IRRITATION;

ADULT; AGED; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EQUIPMENT DESIGN; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; PAIN; PATIENT PREFERENCE; PATIENT SELECTION; SYRINGES; YOUNG ADULT;

EID: 70349451256     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2009.0048     Document Type: Article

References (15)

1. Korythowski M, Bell D, Jacobson C, Suwannasari R; Flex Pen Study Team: A multicentre, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;25:2836-2848.
2. Klonoff DC: The pen is mightier than the needle (and syringe). Diabetes Technol Ther 2001;3:631-633.
3. Lteif AN, Schwenk WF: Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 1999;22:137-140.
4. Asakura T, Seino H, Jensen KH: Patient acceptance and issues of education of two durable insulin pen devices. Diabetes Technol Ther 2008;10:299-304.
5. Garg S, Kelly WC, Garg S: Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes. Expert Rev Med Devices 2008;5:113-123.
6. Thurman JE: Insulin pen injection devices for management of patients with type 2 diabetes: Considerations based on an endocrinologist's practical experience in the United States. Endocr Pract 2007;13:672-678.
7. Korytkowski M, Niskanen L, Asakura T: FlexPen: Addressing issues of confidence and convenience in insulin delivery. Clin Ther 2005;27(Suppl B):S89-S100.
8. Penfornis A, Horvat K: Dose accuracy comparison between SoloSTAR and FlexPen at three different dose levels. Diabetes Technol Ther 2008;10:359-362.
9. Asakura T, Seino H, Jensen KH: Patient acceptance and issues of education of two durable insulin pen devices. Diabetes Technol Ther 2008;10:299-304.
10. Brunton S. Initiating insulin therapy in type 2 diabetes: Benefits of insulin analogs and insulin pens. Diabetes Technol Ther 2008;10:247-256.
11. Cefalu WT: Evolving strategies for insulin delivery and therapy. Drugs 2004;64:1149-1161.
12. Arendt-Nielsen L, Egekvist H, Bjerring P: Pain following controlled cutaneous insertion of needles with different diameters. Somatosens Motor Res 2006;23:37-43.
13. Puder JJ, Atar M, Muller B, Pavan M, Keller U: Using insulin pen needles up to five times does not affect needle tip shape nor increase pain intensity. Diabetes Res Clin Pract 2005;67: 119-123.
14. Jamal R, Ross SA, Parkes JL, Pardo S, Ginsberg BH: Role of injection technique in use of insulin pens: Prospective evaluation of a 31-gauge, 8-mm insulin pen needle. Endocr Pract 1999;5:245-250.
15. Schuler G, Pelz K, Kerp L: Is the reuse of needles for insulin injection systems associated with a higher risk of cutaneous complications? Diabetes Res Clin Pract 1992;16:209-212.